Review: taking Lamictal and Nuvaring together


Summary

Drug interactions are reported among people who take Lamictal and Nuvaring together. This review analyzes the effectiveness and drug interactions between Lamictal and Nuvaring. It is created by eHealthMe based on reports of 74 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Lamictal and Nuvaring >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Lamictal

Lamictal has active ingredients of lamotrigine. It is often used in bipolar disorder. (latest outcomes from Lamictal 40,259 users)

Nuvaring

Nuvaring has active ingredients of ethinyl estradiol; etonogestrel. It is often used in birth control. (latest outcomes from Nuvaring 10,010 users)

On Jul, 23, 2016

74 people who take Lamictal, Nuvaring are studied.


Number of reports submitted per year:

Lamictal and Nuvaring drug interactions.

Drug effectiveness over time:

Lamictal:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 50.0% - (2 of 4 people)
  • 6 - 12 months: 80.0% - (4 of 5 people)
  • 1 - 2 years: 100.0% - (4 of 4 people)
  • 2 - 5 years: 50.0% - (2 of 4 people)
  • 5 - 10 years: 100.0% - (3 of 3 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 100.0% - (1 of 1 people)
Nuvaring:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 80.0% - (4 of 5 people)
  • 1 - 2 years: 100.0% - (3 of 3 people)
  • 2 - 5 years: 75.0% - (6 of 8 people)
  • 5 - 10 years: 100.0% - (3 of 3 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 100.0% - (1 of 1 people)

Drug effectiveness by gender:

Lamictal:
  • female: 69.0% - (16 of 23 people)
  • male: 0.0% - (0 of 0 people)
Nuvaring:
  • female: 86.0% - (19 of 22 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Lamictal:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 61.0% - (8 of 13 people)
  • 30-39: 100.0% - (7 of 7 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Nuvaring:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 84.0% - (11 of 13 people)
  • 30-39: 100.0% - (6 of 6 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • vomiting
  • abdominal pain
  • agitation
  • anaemia
  • anxiety
  • asthenia
  • cerebral thrombosis
  • depressed mood
  • depression aggravated
  • diarrhoea
1 - 6 months:
  • depression
  • cognitive deterioration
  • drug exposure during pregnancy
  • ear pain
  • early morning joint stiffness
  • fatigue
  • grand mal convulsion
  • headache
  • hypertrophy breast
  • lightheadedness
6 - 12 months:
  • apraxia
  • confusion
  • fatigue
  • memory impairment
  • mood swings
  • muscle twitching
  • tremor
  • depression
  • euphoric mood
  • headache
1 - 2 years:
  • fatigue
  • cognitive deterioration
  • complication of device insertion
  • ear pain
  • early morning joint stiffness
  • headache
  • lightheadedness
  • metrorrhagia
  • muscle pain
  • pressure sore
2 - 5 years:
  • agitation
  • anxiety
  • depressed mood
  • depression aggravated
  • diarrhoea
  • drug effect decreased
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • intermenstrual bleeding
  • night sweats
  • paranoia
5 - 10 years:
  • fatigue
  • apraxia
  • confusion
  • memory impairment
  • mood swings
  • muscle twitching
  • tremor
  • depression
  • euphoric mood
  • headache
not specified:
  • metrorrhagia
  • abdominal pain upper
  • abdominal pain
  • bile duct stone
  • cholecystitis acute
  • hyperbilirubinaemia
  • anaemia
  • headache
  • insomnia
  • nausea

Most common drug interactions by gender *:

female:
  • metrorrhagia
  • fatigue
  • headache
  • depression
  • nausea
  • abdominal pain upper
  • mood swings
  • abdominal pain
  • anaemia
  • anxiety

Most common drug interactions by age *:

10-19:
  • depression
  • drug administration error
  • epilepsy
  • fatigue
  • hypertrophy breast
  • incoherent
  • malaise
  • obsessive-compulsive disorder
  • overdose
  • pregnancy on contraceptive
20-29:
  • abdominal pain upper
  • bile duct stone
  • cholecystitis acute
  • hyperbilirubinaemia
  • metrorrhagia
  • fatigue
  • pulmonary tuberculosis
  • rash
  • abdominal pain
  • agitation
30-39:
  • mood swings
  • apraxia
  • confusion
  • fatigue
  • headache
  • memory impairment
  • muscle twitching
  • nausea
  • tremor
  • amenorrhoea
40-49:
  • anaemia
  • menstruation irregular
  • nausea
  • pelvic pain
  • uterine leiomyoma
  • abdominal pain
  • anticonvulsant drug level decreased
  • asthenia
  • depression
  • diarrhoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Lamictal and Nuvaring?

Can you answer these questions?

More questions for: Lamictal, Nuvaring

You may be interested in these reviews

More reviews for: Lamictal, Nuvaring

On eHealthMe, Lamictal (lamotrigine) is often used to treat bipolar disorder. Nuvaring (ethinyl estradiol; etonogestrel) is often used to treat birth control. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.